Axon Enterprise, Inc. (NASDAQ:AXON) Position Cut by Bridges Investment Management Inc.

Bridges Investment Management Inc. trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 25.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 570 shares of the biotechnology company’s stock after selling 199 shares during the quarter. Bridges Investment Management Inc.’s holdings in Axon Enterprise were worth $339,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its stake in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC raised its stake in shares of Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new stake in shares of Axon Enterprise during the third quarter valued at about $200,000. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC restated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Northland Securities lifted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Insider Buying and Selling

In related news, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the transaction, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,407 shares of company stock valued at $4,122,925. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Trading Down 0.5 %

Shares of AXON opened at $525.75 on Tuesday. The business’s 50-day moving average price is $607.58 and its 200 day moving average price is $526.43. The stock has a market capitalization of $40.09 billion, a P/E ratio of 135.85, a P/E/G ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.